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Abstract
Background: In some randomized trials successful laparoscopic cholecystectomy for cholecystitis
is associated with an earlier recovery and shorter hospital stay when compared with open
cholecystectomy. Other studies did not confirm these results and showed that the potential
advantages of laparoscopic cholecystectomy for cholecystitis can be offset by a high conversion rate
to open surgery. Moreover in these studies a similar postoperative programme to optimize
recovery comparing laparoscopic and open approaches was not standardized. These studies also
do not report all eligible patients and are not double blinded.
Design: The present study project is a prospective, randomized investigation. The study will be
performed in the Department of General, Emergency and Transplant Surgery St Orsola-Malpighi
University Hospital (Bologna, Italy), a large teaching institutions, with the participation of all
surgeons who accept to be involved in (and together with other selected centers). The patients will
be divided in two groups: in the first group the patient will be submitted to laparoscopic
cholecystectomy within 72 hours after the diagnosis while in the second group will be submitted
to laparotomic cholecystectomy within 72 hours after the diagnosis.
Trial Registration: TRIAL REGISTRATION NUMBER ISRCTN27929536 – The ACTIVE (Acute
Cholecystitis Trial Invasive Versus Endoscopic) study. A multicentre randomised, double-blind,
controlled trial of laparoscopic versus open surgery for acute cholecystitis in adults.
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Introduction
In the developmental stage of laparoscopic cholecystec-
tomy it was considered 'unsafe' or 'technically difficult' to
perform laparoscopic cholecystectomy for acute cholecys-
titis [1,2]. With increasing experience in laparoscopic sur-
gery, a number of centers have reported on the use of
laparoscopic cholecystectomy for acute cholecystitis, sug-
gesting that it is technically feasible but at the expense of
a high conversion rate, which can be up to 35 per cent
[3,4] and common bile duct lesions [5].
Several randomized studies in the early 1980s had shown
that performing early open cholecystectomy for acute
cholecystitis was better than delayed cholecystectomy in
terms of shorter hospital stay but both had similar opera-
tive morbidity and mortality rates [3]. Early surgery had
since gained in popularity in the late 1980s [2]. Routine
use of the open procedure might enable more patients to
have the operations during the acute phase because most
surgeons are practiced in this approach. The impact of
hospital stay and morbidity must also be taken into
account. There is the expectation that open operation is
associated with more pain and longer hospital stay [6-8].
In some trials successful laparoscopic cholecystectomy
during the period of acute inflammation is associated
with an earlier recovery and shorter hospital stay when
compared with open cholecystectomy [8]. Other studies
did not confirm these results and the potential advantages
of early laparoscopic cholecystectomy can be offset by a
high conversion rate to open surgery [5]. Moreover in
these studies a similar postoperative programme to opti-
mize recovery comparing laparoscopic and open
approaches was not standardized. Many studies also do
not report all eligible patients and are not double blinded.
Methods
Design
The study project is a prospective, randomized investiga-
tion. The study will be performed in the Department of
Emergency Surgery St Orsola-Malpighi University Hospi-
tal (Bologna, Italy), a large teaching institutions, with the
participation of all surgeons who accept to be involved in
(and together with other selected centers).
The patients will be divided in two groups: in the first
group the patient will be submitted to early LC (Laparo-
scopic Cholecystectomy) within 72 hours after the diag-
nosis of cholecystitis while in the second group will be
submitted to early LTC (LaparoTomic Cholecystectomy)
within 72 hours after the diagnosis.
Randomization
The randomization will be obtained through computer-
generated schedule. The result of this randomization will
be sealed in numbered envelopes. After cholecystitis diag-
nosis if the patient fulfils the inclusion criteria the respon-
sible surgeon will ask the patient to partecipate to the
study. If the patient agree, he/she will sign the informed
consent. After patient's consent the randomization will be
carried out. The responsible surgeon will record the
patient name (and number). All eligible patients will be
recorded.
Statistics
Sample size has been calculated to reach a confidence
level of 95% with a power of 80%.
A sample size of 144 patients is calculated supposing that
the hospital stay for LC is shorter than 2 days. The sample
size will be 72 patients for each group (144 patients for
the whole study).
For comparison of the two groups, chi-square analysis and
Fisher's exact test are used when appropriate for qualita-
tive data, and the Student t-test (for normal variables) or
the Mann Whitney U-test (for nonnormal variables) for
quantitative data. For multivariate analysis the stepwise
logistic regression is applied. A probability of 0.05 or less
is accepted as statistically significant.
Inclusion And Exclusion Criteria
Inclusion criteria are:
Adult patients (>18 years)
Clinical (pain, fever > 37.5°C, WBC > 10.000/microL),
and ultrasound evidence of cholecystitis
ASA I-III patients
Informed consent
Less than 72 h from the onset
Exclusion criteria
Informed consent refusal
Choledocholithiasis
Generalized peritonitis
Previous abdominal surgical procedures
Patients with an intra-operative findings of different
pathology will be excluded from the study
Apache II score > 10Trials 2008, 9:1 http://www.trialsjournal.com/content/9/1/1
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Intervention
Preoperative data collected will include patient demo-
graphics and comorbid conditions (genitourinary, car-
diac, pulmonary, gastrointestinal, renal, or
rheumatologic) and a detailed history of symptom onset.
The procedure was performed by a surgeon that had per-
formed at least 50 LCs.
On admission, the patients were started on cefotaxime, 2
g IV every 12 h, which was continued postoperatively
according to NNISS score [9].
The standard four-trocar operative technique is used for
LC for acute cholecystitis.
When the gallbladder is distended it will be first aspirated.
To allow a good hold on the gallbladder larger graspers
will be inserted through a 5 mm right lower port. The
cystic artery and duct are clip-ligated. The gallbladder and
intraperitoneal "dropped" stones are collected in an endo-
scopic bag and extracted through the umbilical cannula
site, which can be extended. A closed system suction drain
is left. Fascial closure is attempted only at the umbilical
cannula site. The skin at all the cannula sites are closed
with staples.
Laparotomic procedure is carried out with an about 8 cm
right subcostal incision and the traditional surgical tech-
nique with a closed system suction drain left in situ.
Data Collection
Patients' data sheets are generated containing demo-
graphic data and preoperative, operative, and postopera-
tive information.
Pre-operative notes concern the history of gallbladder
stones, the presence of associated diseases (cardiac, hyper-
tension, diabetes, malignancy), duration of gallbladder
complaints (as an indication for the onset of the disease),
finding of a palpable gallbladder, temperature, and labo-
ratory results of WBC count, serum bilirubin, gamma GT,
PCR, IL-6 and alkaline phosphatase. Ultrasound findings
are also reported.
Operative data of concern are macroscopic findings (of
acute cholecystitis, gangrenous cholecystitis, hydrops, and
empyema of the gallbladder), the presence of small stones
(< 1 cm diameter) or large bile stones (> 1 cm diameter),
information regarding perforation of the gallbladder and
intraperitoneally "lost" stones, reasons for conversion,
and duration of surgery. Postoperative notes of interest
included the use of nasogastric tubes and drains, the
amount of analgesics used, (evaluation of pain with VAS
score), complications, and length of hospital stay.
Complications are classified as surgical infections (wound
infection, subphrenic or subhepatic abscess); noninfec-
tious surgical problems (e.g., bile duct injury, hemor-
rhage); remote infections (urinary or respiratory); and
miscellaneous problems (e.g., atelectasis, deep vein
thrombosis, AMI, CVA, etc). The collected information are
entered into a database as either continuous or categorical
variables for statistical analysis. Following the operative
procedure, a large sterile dressing will be applied to cover
the entire abdomen.
A second surgical team, aware of the operative findings
but not the surgical access approach, then will assume the
care of the patient. Postoperative care and ability to be dis-
charged from the hospital will be determined by the sec-
ond surgical team. This second surgical team will be
blinded to the surgical approach. The primary operative
team will be in every moment available for emergent con-
sultation or evaluation of the wound.
In the pre-anaesthetic holding area, baseline pain will be
investigated at rest and on coughing using a pain-rating
scale systems: a 100-mm visual analogue scales (VAS) (0
= minimal and 100 = maximal).
An investigator blinded to the study operation performed,
will evaluate postoperative pain intensity on returning to
the Surgical Ward (zero time), and after 12 and 24 hours
(± 3 hours). The three hours of tolerance (before or after
the precise time of control) will be used in order to avoid
to awake the patients during the night. But during the day
time, if asleep, the patient will be awakened for the pain
test. At these timed intervals, the following variable will be
recorded: VAS for pain at rest, and on coughing; if, at rest,
VAS is more than 3, the patient will be given intravenous
30 mg ketorolac. The pain tests will be also performed
whenever the patient ask for additional analgesia between
the timed controls and parenteral analgesics will be
administered accordingly. Every time the patient under-
goes the pain test, he will be asked about the location of
pain (in the surgical wound, far from the wound, every-
where or does not know). As soon as patients will begin
to drink fluid instead of ketorolac 30 mg iv, they will be
offered nimesulide 100 mg 1 tab orally prn (max 2 tabs
daily). Orally administered analgesics will be continued
in preference to parenterally administered analgesics if
they will be efficacious. After discharge, the patients will
be offered nimesulide 100 mg 1 tab orally prn (max 2 tabs
daily). Also parenteral and oral analgesic drug require-
ments will be recorded and analyzed as a measure of post-
operative pain. Furthermore the patient satisfaction with
the analgesia provided (using a scale of poor, satisfactory,
good, or excellent) will be recorded before discharge and
after 7 days.Trials 2008, 9:1 http://www.trialsjournal.com/content/9/1/1
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Patient discharge will be based on good medical practice
criteria: 1) apyrexia 2) absence of diseases requiring hos-
pitalisation 3) return of bowel function 4) patient's com-
pliance.
Informed Consent Form Or Information Sheet
In the informed consent form, patients will receive all the
information about the study protocol, the confidential
nature of personal data and will fill up a questionnaire
before signing or refuse. There will be not inconveniences
caused to the patients. No incentives are planned for the
patients regarding the operation or the follow-up. All the
medical informations obtained from the patients will be
kept confidentially among the research scientists conduct-
ing the study. The patients will be free to withdraw from
the study, whenever they want without any obligation.
Ethical Approval
Approved by the ethical Committee of the Saint Orsola-
Malpighi Hospital (see Additional files 1 and 2).
Primary Endpoints
The aim of the study is to compare the results of early
laparoscopic and laparotomic cholecystectomy for acute
cholecystitis in terms of morbidity, mortality, conversion
rate, operation time, hospital stay, postoperative pain,
return to normal activity and aesthetic result.
The primary endpoints of our study will be:
To evaluate the value of laparoscopic cholecystectomy to
reduce hospital stay
To evaluate the value of laparoscopic cholecystectomy to
reduce postoperative pain
To evaluate the conversion rate
The onset of any other complications will be recorded
intraoperatively, postoperatively, at discharge, at 7-days,
1-month and 6-months.
All the above mentioned data will be recorded in the Case
Report Form and later stored in computer database. At the
end of the study the final statistical examination will be
carried out.
An interim statistical examination of the data will be done
every 3 months during the period of patients' inclusion in
the study. Then at the end of every completed follow-up
period (1-month, 6-months).
The statistical analysis will be carried out using Epi Info
2000, Version 1.1 software package (Dean AG, Arner TG,
Sangam S, Sunki GG, Friedman R, Lantinga M, Zubieta JC,
Sullivan KM, Smith DC. Epi Info 2000, a database and sta-
tistics program for public health professionals for use on
Windows 95, 98, NT, and 2000 computers; Centers for
Disease Control and Prevention, Atlanta, Georgia, USA,
2000)
No incentives are planned for the patients regarding the
operation or the follow-up.
The study will take approximately 6 months – 1 year for
the inclusion period. According to the number of AC
menaged monthly in all Centers, the duration of the
inclusion period can be approximately of 1 year to reach
the number of about 144 enrolled patients.
An interim report is planned at the end of any completed
follow-up period.
AC is a common disease. Any improvement in this field
will benefit many patients reducing morbidity, mortality,
conversion rate, operation time, hospital stay, postopera-
tive pain, return to normal activity and aesthetic result. All
our patients will be informed about the study and an
informed consent will be obtained. There will not be
inconveniences caused to the patients. All the medical
informations obtained from the patients will be kept con-
fidentially among the research scientists conducting the
study. The patients will be free to withdrawn from the
study, whenever they want without any obligation.
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